Barclays
GHSI

Barclays’s Guardion Health Sciences, Inc. Common Stock GHSI Stock Holding History

Barclays’s Portfolio GHSI Stock Details GHSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-742
Closed -$5.48K – 5385
2023
Q3 		$5.48K Sell
742
-158
-18% -$1.22K ﹤0.01% 4373
2023
Q2 		$7K Sell
900
-4,100
-82% -$25.8K ﹤0.01% 4246
2023
Q1 		$30.6K Hold
5,000
– – ﹤0.01% 4566
2022
Q4 		$36.3K Hold
5,000
– – ﹤0.01% 4657
2022
Q3 		$35K Hold
5,000
– – ﹤0.01% 3888
2022
Q2 		$36K Buy
+5,000
New +$43.7K ﹤0.01% 4177
2020
Q4 		– Hold
0
– – – 5205
2020
Q3 		– Hold
0
– – – 5671
2020
Q2 		– Sell
-333
Closed -$46.4K – 6377
2020
Q1 		$46K Sell
333
-366
-52% -$38.7K ﹤0.01% 5278
2019
Q4 		$46K Buy
+699
New +$66.7K ﹤0.01% 5761

Other funds holding GHSI

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
CPG
Cornerstone Planning Group Fairfield, New Jersey $749M AUM 17.97% 1-Year Est. Return
S
SignatureFD Atlanta, Georgia $6.53B AUM 20.48% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Barclays's GHSI Position: Q4 2023 in Review

Barclays sold out of Guardion Health Sciences, Inc. Common Stock (GHSI) in Q4 2023, closing a stake of 742 shares — an estimated $5.48K sold.

Barclays first reported a position in GHSI in Q4 2019 and held it in 8 quarters. The position peaked at $46K in Q1 2020. 11 funds tracked by Wall St. Rank hold GHSI as of Q4 2023.

  • Barclays reported no remaining Guardion Health Sciences, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Barclays sold 742 Guardion Health Sciences, Inc. Common Stock shares in Q4 2023, an estimated $5.48K.
  • Barclays first reported a position in Guardion Health Sciences, Inc. Common Stock in Q4 2019 and held it in 8 quarters.
  • Barclays's Guardion Health Sciences, Inc. Common Stock position peaked at $46K in Q1 2020.
  • 11 funds tracked by Wall St. Rank held Guardion Health Sciences, Inc. Common Stock as of Q4 2023.

Based on Barclays's 13F filing for Q4 2023, filed 15 Feb 2024.